0001401708-20-000162.txt : 20200819 0001401708-20-000162.hdr.sgml : 20200819 20200819164012 ACCESSION NUMBER: 0001401708-20-000162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200817 FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HERSHBERG ROBERT CENTRAL INDEX KEY: 0001274139 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35980 FILM NUMBER: 201117492 MAIL ADDRESS: STREET 1: 3005 FIRST AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoString Technologies Inc CENTRAL INDEX KEY: 0001401708 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 200094687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-6266 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 4 1 wf-form4_159786959791161.xml FORM 4 X0306 4 2020-08-17 0 0001401708 NanoString Technologies Inc NSTG 0001274139 HERSHBERG ROBERT C/O NANOSTRING TECHNOLOGIES, INC. 530 FAIRVIEW AVENUE N SEATTLE WA 98109 1 0 0 0 Common Stock 2020-08-17 4 M 0 1500 11.20 A 3390 D Common Stock 2020-08-17 4 S 0 414 37.71 D 2976 D Common Stock 2020-08-17 4 S 0 846 38.44 D 2130 D Common Stock 2020-08-17 4 S 0 240 39.26 D 1890 D Stock Option (right to buy) 11.2 2020-08-17 4 M 0 1500 11.20 D 2025-03-01 Common Stock 1500.0 10188 D The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.08 to $37.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.13 to $39.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.15 to $39.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. 50% of the shares subject to the Option vest on the one year anniversary of March 2, 2015 (the "Vesting Commencement Date") and thereafter the remaining 50% of the total shares vest in twelve equal monthly installments on each monthly anniversary of the Vesting Commencement Date, subject to continued service as a director through each vesting date. /s/ Shannon Atchison, Attorney-in-fact 2020-08-19